About Kenneth Morand
Kenneth Morand is a partner, cincytech and director at Eikonoklastes Therapeutics.
Kenneth Morand first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Kenneth Morand in the role, so the role may have started earlier or lasted longer.
Eikonoklastes Therapeutics, Inc.
Partner, CincyTech and director
2021 – 2026 · Cincinnati, OH
Develops gene therapies for people with ALS and other neurodegenerative diseases.
Key Colleagues at Startups
The people Kenneth Morand works with at each company, as listed on that company's latest Form D.
Eikonoklastes Therapeutics, Inc. · Form D/A, Oct 6, 2026
Bruce Halpryn
Chairman and Chief Executive Officer
SL
Samuel Lee
President and Chief Business Officer, director
TF
Thomas Finn
Director
RJ
Robert Johnson
CEO, Kesmalea Therapeutics and director
JN
Joseph Nolan
CEO, Jaguar Gene Therapy and director